Benutzer: Gast  Login
Titel:

Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.

Dokumenttyp:
Article; Journal Article; Randomized Controlled Trial
Autor(en):
Coughlan, J J; Aytekin, Alp; Lahu, Shqipdona; Ndrepepa, Gjin; Menichelli, Maurizio; Mayer, Katharina; Wöhrle, Jochen; Bernlochner, Isabell; Gewalt, Senta; Witzenbichler, Bernhard; Hochholzer, Willibald; Sibbing, Dirk; Cassese, Salvatore; Angiolillo, Dominick J; Hemetsberger, Rayyan; Valina, Christian; Müller, Arne; Kufner, Sebastian; Liebetrau, Christoph; Xhepa, Erion; Hapfelmeier, Alexander; Sager, Hendrik B; Joner, Michael; Fusaro, Massimiliano; Richardt, Gert; Laugwitz, Karl Ludwig; Neumann,...     »
Abstract:
Importance: It is unclear whether ticagrelor or prasugrel hydrochloride is superior for patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). Objective: To assess the safety and efficacy of ticagrelor vs prasugrel for patients with ACS treated with PCI. Design, Setting, and Participants: A prespecified analysis was performed of a postrandomization subgroup of 3377 patients who presented with ACS and were treated with PCI in the investigator-initiated,...     »
Zeitschriftentitel:
JAMA Cardiol
Jahr:
2021
Band / Volume:
6
Heft / Issue:
10
Seitenangaben Beitrag:
1121-1129
Volltext / DOI:
doi:10.1001/jamacardio.2021.2228
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/34190967
Print-ISSN:
2380-6583
TUM Einrichtung:
289; Institut für Medizinische Statistik und Epidemiologie; Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert); Klinik und Poliklinik für Innere Medizin I, Kardiologie; Lehrstuhl für Allgemeinmedizin (Prof. Schneider) (keine SAP-Zuordnung!)
 BibTeX